NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Glas M, Bähr O, Felsberg J, Rasch K, Wiewrodt D, Schabet M, Simon M, Urbach H, Steinbach JP, Rieger J, Fimmers R, Bamberg M, Nägele T, Reifenberger G, Weller M, Herrlinger U; Neuro-Oncology Group of the German Cancer Society.
Glas M, et al. Among authors: herrlinger u.
Ann Neurol. 2011 Sep;70(3):445-53. doi: 10.1002/ana.22478. Epub 2011 Jun 27.
Ann Neurol. 2011.
PMID: 21710625
Clinical Trial.